US NCI, BMS project evaluates digital signatures in speeding trial start dates
This article was originally published in SRA
Executive Summary
Results of the first phase of an ongoing pilot project in the US by the National Cancer Institute Cancer Therapy Evaluation Program (CTEP) and Bristol-Myers Squibb have demonstrated that, compared with the use of paper hard copy documents, the use of digital signatures and cloud computing saved significant time and costs of initiating clinical trials, while also ensuring researcher and patient identities were protected.